Senestech, Inc. (NASDAQ:SNES) Sees Significant Increase in Short Interest

Senestech, Inc. (NASDAQ:SNES) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 49,411 shares, an increase of 127.9% from the February 12th total of 21,680 shares. Based on an average daily trading volume, of 72,794 shares, the short-interest ratio is currently 0.7 days. Currently, 1.0% of the shares of the company are short sold. Currently, 1.0% of the shares of the company are short sold. Based on an average daily trading volume, of 72,794 shares, the short-interest ratio is currently 0.7 days.

Insider Activity at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management acquired 42,739 shares of the company’s stock in a transaction on Monday, February 2nd. The stock was acquired at an average price of $1.98 per share, for a total transaction of $84,623.22. Following the purchase, the insider directly owned 593,785 shares of the company’s stock, valued at $1,175,694.30. This trade represents a 7.76% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders have acquired 173,954 shares of company stock valued at $367,303 in the last 90 days. 5.29% of the stock is owned by insiders.

Institutional Investors Weigh In On Senestech

Institutional investors and hedge funds have recently made changes to their positions in the business. XTX Topco Ltd bought a new position in Senestech during the fourth quarter valued at approximately $54,000. Sabby Management LLC boosted its stake in shares of Senestech by 195.4% in the 4th quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock valued at $451,000 after purchasing an additional 139,281 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Senestech in the 4th quarter valued at $32,000. DRW Securities LLC grew its holdings in shares of Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after purchasing an additional 51,818 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in Senestech by 35.2% in the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after purchasing an additional 37,165 shares during the period. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Senestech Stock Down 16.8%

Shares of Senestech stock traded down $0.38 on Friday, hitting $1.88. The company had a trading volume of 240,531 shares, compared to its average volume of 53,464. Senestech has a 1 year low of $1.30 and a 1 year high of $6.24. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. The stock has a 50 day moving average of $2.08 and a 200-day moving average of $3.06. The stock has a market capitalization of $9.81 million, a price-to-earnings ratio of -0.52 and a beta of 0.15.

Senestech (NASDAQ:SNES) last announced its earnings results on Thursday, March 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.01. The firm had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.78 million. Senestech had a negative return on equity of 98.35% and a negative net margin of 253.54%. As a group, sell-side analysts forecast that Senestech will post -10.22 earnings per share for the current year.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.